Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Gains from Investment Securities (2023 - 2026)

BioAge Labs' Gains from Investment Securities history spans 3 years, with the latest figure at $230961.0 for Q3 2025.

  • On a quarterly basis, Gains from Investment Securities rose 344.99% to $230961.0 in Q3 2025 year-over-year; TTM through Dec 2025 was $3.3 million, a N/A change, with the full-year FY2025 number at $3.0 million, down 44.94% from a year prior.
  • Gains from Investment Securities hit $230961.0 in Q3 2025 for BioAge Labs, down from $2.9 million in the prior quarter.
  • Over the last five years, Gains from Investment Securities for BIOA hit a ceiling of $3.1 million in Q1 2025 and a floor of -$102000.0 in Q4 2024.
  • Historically, Gains from Investment Securities has averaged $1.1 million across 3 years, with a median of $252480.5 in 2024.
  • Biggest five-year swings in Gains from Investment Securities: tumbled 104.31% in 2024 and later surged 38725.0% in 2025.
  • Tracing BIOA's Gains from Investment Securities over 3 years: stood at $2.4 million in 2023, then tumbled by 104.31% to -$102000.0 in 2024, then surged by 326.43% to $230961.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for BIOA at $230961.0 in Q3 2025, $2.9 million in Q2 2025, and $3.1 million in Q1 2025.